Phillip M. Pierorazio, MD, presented “Recent Findings on Upper Tract Urothelial Carcinoma Presented at the AUA’s 2019 Annual Meeting” for the Grand Rounds in Urology audience in August, 2019.
How to cite: Pierorazio, Phillip M. “Recent Findings on Upper Tract Urothelial Carcinoma Presented at the AUA’s 2019 Annual Meeting” August, 2019. Accessed Nov 2025. https://grandroundsinurology.com/recent-findings-on-upper-tract-urothelial-carcinoma-presented-at-the-auas-2019-annual-meeting/
Recent Findings on Upper Tract Urothelial Carcinoma Presented at the AUA’s 2019 Annual Meeting – Summary:
Phillip M. Pierorazio, MD, reviews data from one presentation and two moderated posters at the American Urological Association’s 2019 Annual Meeting related to upper tract urothelial cancer (UTUC). He discusses the promising efficacy of UGN-101 to treat low-grade UTUC as shown in the OLYMPUS trial, details data that supports the use of intravesical therapy to prevent recurrence of bladder cancer in patients with upper-tract disease, and argues that concordant or discordant pathology should have little bearing on treatment options for patients suspected of having high-grade UTUC.
For more information on upper-tract urothelial carcinoma, please visit our next-generation learning center.
ABOUT THE AUTHOR
Philip M. Pierorazio, MD, is a Professor of Surgery at the University of Pennsylvania in Philadelphia, Pennsylvania. He also serves as chief of the section of urology at Penn Presbyterian Medical Center. Dr. Pierorazio graduated from Georgetown University in Washington, DC and earned his MD from Columbia University.
Dr. Pierorazio is a board-certified urologist with training and expertise in urologic cancers. He has expertise in all malignancies of the urinary tract, but his clinical and academic practice focuses on kidney cancer (renal cell carcinoma), testicular cancer (germ cell tumors), upper tract urothelial cancer, and prostate cancer. Additionally, Dr. Pierorazio directs the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry - one of the largest active surveillance registries for patients with small kidney tumors. He also serves as a member of many professional organizations, such as the American Urological Association (AUA) and National Comprehensive Cancer Network (NCCN) Guidelines Committee for Kidney, Testicular and Upper Tract Urothelial Cancer.
